Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The C-type natriuretic peptide receptor encompasses two main receptor types: NPR-B (also known as guanylyl cyclase-B or GC-B) and NPR-C. NPR-B is primarily activated by CNP, leading to increased intracellular cGMP and vasodilation. It plays a critical role in bone growth. NPR-C binds all natriuretic peptides and primarily functions as a clearance receptor, although it also signals through G proteins. Both receptors influence cardiovascular function and metabolic regulation, making them potential therapeutic targets for diseases like heart failure and metabolic syndrome.
Guanylyl cyclase activation (NPR-B), cGMP production; G protein-coupled inhibition of adenylyl cyclase (NPR-C), Natriuretic peptide clearance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-type Natriuretic Peptide Receptor.